NFKB1 and neoplasm: However, tumor cells can enhance PD-L1 transcription by activating transcriptional regulatory factors that modulate the JAK/STAT1/IRF1, NF-κB, and JAK/STAT3 signaling pathways in response to various cytokine stimuli (21, 22).